News
01-09-2018, 08:54 PM
Researchers at the University of Cincinnati College of Medicine have identified for the first time that the estrogen receptor-binding protein MED1 is a critical mediator of HER2-driven breast cancer, identifying it as a potential therapeutic target.
More... (https://www.news-medical.net/news/20180109/UC-scientists-identify-protein-that-acts-as-mediator-of-HER2-driven-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20180109/UC-scientists-identify-protein-that-acts-as-mediator-of-HER2-driven-breast-cancer.aspx)